DRRX 241220 2.00P (DRRX241220P2000) Stock Options, News & Quotes

US OptionsDetailed Quotes

DRRX241220P2000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 27 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Oppenheimer Remains a Buy on Durect (DRRX)
TipRanksNov 26 07:46 ET · Ratings
Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro
ReutersNov 25 11:34 ET
DURECT Sells ALZET Osmotic Pumps for $17.5M, Pays Off Loan Obligations
BenzingaNov 25 06:05 ET
Express News | DURECT Corp - Transaction Extends DURECT Cash Runway Through First Half of 2025
ReutersNov 25 06:00 ET
Express News | DURECT Corporation Announces Sale of Alzet® Product Line to Lafayette Instrument Co. for $17.5 Million
ReutersNov 25 06:00 ET
Branford Castle-Backed Lafayette Instrument Acquires Alzet Osmotic Pumps
PR NewswireNov 25 06:00 ET

Comments

Jaguar8

Nov 25 05:07

NEWS

$Durect (DRRX.US)$
DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million
DURECT (DRRX) has sold its ALZET® osmotic pumps product line to Lafayette Instrument Co. for $17.5 million. The transaction includes certain assets and liabilities associated with the ALZET line.
DURECT used the proceeds to pay off its remaining obligations under the Oxford Finance term loan.
The company states this sale strengthens its cash position and extends runway t...

Form 4

NEWS

$Durect (DRRX.US)$
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
Type B meeting with FDA held under Breakthrough Therapy designation resulted in agreement on key aspects of Phase 3 trial design
- Single Phase 3 trial designed to enroll 200 U.S. patients with a 90-day survival primary endpoint;topline results expected within two years of trial initiation
- Protocol for Phase 3 trial builds on data from the AHFIRM Phase 2b tr...

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...